Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatients

Abstract Viral clearance, antibody response and the mutagenic effect of molnupiravir has not been elucidated in at-risk populations.Non-hospitalised participants within 5 days of SARS-CoV-2 symptoms randomised to receive molnupiravir (n = 253) or Usual Care (n = 324) were recruited to study viral and antibody dynamics and the effect of molnupiravir

read more




MicroRNA-802 Inhibits Cell Proliferation and Induces Apoptosis in Human Laryngeal Cancer by Targeting cAMP-Regulated Phosphoprotein 19 [Retraction]

Ye H, Jin Q, Wang X, Li Y.Cancer Management and Research.2020;12:419–430.The Editor and Publisher of Cancer Management and Research wish to retract the published article.Concerns were raised over the alleged image duplication in yale law school colors Figures 2E and 4F with similar images from unrelated articles, specifically: Figure 2E, pane

read more